Regeneron Pharmaceuticals (REGN) had the highest return in 2012 by a large-cap US stock, returning 202.7%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Regeneron Pharmaceuticals (REGN) | 2012 | 202.72% |
PulteGroup (PHM) | 2012 | 180.68% |
Builders FirstSource (BLDR) | 2012 | 165.71% |
Alnylam Pharmaceuticals (ALNY) | 2012 | 119.09% |
Insmed (INSM) | 2012 | 114.42% |
Genmab A-S (GMAB) | 2012 | 114.07% |
Cheniere Energy (LNG) | 2012 | 111.25% |
Expedia (EXPE) | 2012 | 110.3% |
Westlake Chemical (WLK) | 2012 | 104.76% |
Bank of America (BAC) | 2012 | 102.89% |
Nomura Holdings Inc ADR (NMR) | 2012 | 100.41% |
Lloyds Banking Group PLC ADR (LYG) | 2012 | 97.52% |
Lennar (LEN) | 2012 | 93.79% |
Booz Allen Hamilton (BAH) | 2012 | 93.12% |
Lennar (LEN.B) | 2012 | 91.18% |
Seagate Technology (STX) | 2012 | 90.71% |
LyondellBasell Industries (LYB) | 2012 | 89.63% |
Marathon Petroleum (MPC) | 2012 | 87.16% |
Smurfit WestRock (SW) | 2012 | 83.21% |
Illumina (ILMN) | 2012 | 79.32% |
Corpay (CPAY) | 2012 | 79.01% |
Guidewire Software (GWRE) | 2012 | 77.43% |
Gilead Sciences (GILD) | 2012 | 77.16% |
Aptiv (APTV) | 2012 | 73% |
HCA (HCA) | 2012 | 72.75% |
Large-cap stocks are treated as having a market cap of $10B+.
